407 filings
Page 12 of 21
SC TO-C
2gl68vu0qcrkz t21
12 Mar 12
Information about tender offer
12:00am
CERTNYS
rjvt1tar
7 Mar 12
Certification of approval for NYSE listing
12:00am
8-K
tadhjbk90q2yqbrnr2ru
5 Mar 12
Departure of Directors or Certain Officers
12:00am
8-A12B
2qxeeelz3vdm5bpr1g
28 Feb 12
Registration of securities on exchange
12:00am
8-K
6mye4dawvzd96rz5njb7
28 Feb 12
Entry into a Material Definitive Agreement
12:00am
SC TO-C
u6h64kh9xsyllxjnt
27 Feb 12
Information about tender offer
12:00am
8-K
wymxa18
22 Feb 12
Regulation FD Disclosure
12:00am
CORRESP
do8apnbnmdeuy2ht94
21 Feb 12
Correspondence with SEC
12:00am
UPLOAD
snfi9
17 Feb 12
Letter from SEC
12:00am
8-K/A
iwi8om
10 Feb 12
Results of Operations and Financial Condition
12:00am
8-K
3wa1b1ziqr2vxfg
9 Feb 12
Completion of Acquisition or Disposition of Assets
12:00am
8-K
ee14w6aabf
2 Feb 12
Prestige Brands Holdings, Inc. Completes Purchase of 15 Brands from GSK
12:00am
8-K
7ddlql05tdpb yp
25 Jan 12
Prestige Brands Holdings, Inc. Announces Pricing of $250 Million Senior Notes Due 2020
12:00am
8-K
7zsgu7mw
18 Jan 12
Prestige Brands, Inc. Announces Offering of $290 Million Senior Notes
12:00am
CT ORDER
58r 2oeddz
18 Jan 12
Confidential treatment order
12:00am
8-K
kyg4z66 b0hg1g
27 Dec 11
Entry into a Material Definitive Agreement
12:00am
8-K
qmlnt66bntcv
20 Dec 11
Prestige Brands Holdings, Inc. Signs Definitive Agreements With GSK To Acquire 17 Consumer OTC Healthcare Brands in North America
12:00am
8-K
o8fhrbu
9 Nov 11
Prestige Brands Holdings, Inc. Reports Fiscal 2012 Second Quarter Sales Increase of 34.8%; Reported Diluted EPS of $0.26 vs. $0.22
12:00am